Concert Pharmaceuticals Stock News

Concert Pharmaceuticals, Inc. (NASDAQ:CNCE) Stock analysts at Truist Securiti increased their FY2021 earnings per share estimates for Concert Pharmaceuticals in a research note issued on Tuesday, November 9th. Truist Securiti analyst J. Lee now expects that the biotechnology company will post earnings of ($1.89) per share for the year, up from their prior estimate []

Concert Pharmaceuticals, Inc. (CNCE) CEO Roger Tung on Q3 2021 Results - Earnings Call Transcript

Concert (CNCE) delivered earnings and revenue surprises of -2.63% and 117.20%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?

Check these trending penny stocks out for your watchlist The post Are These Trending Penny Stocks Worth Buying at Current Levels? appeared first on Penny Stocks to Buy, Picks, News and Information | P

The stock price of Concert Pharmaceuticals Inc (NASDAQ: CNCE) increased 27.43% today. This is why it happened.

Are these penny stocks on your November watchlist? The post Why These Penny Stocks Popped Today, 3 to Watch appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

Concert (CNCE) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

LEXINGTON, Mass.--(BUSINESS WIRE)---- $CNCE #AlopeciaAreata--In September, Concert will present virtually at the HC Wainwright and Cantor healthcare conferences.

Concert Pharmaceuticals, Inc. (CNCE) CEO Roger Tung on Q2 2021 Results - Earnings Call Transcript

Concert (CNCE) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

LEXINGTON, Mass.--(BUSINESS WIRE)---- $CNCE #AlopeciaAreata--Concert will provide an update on the CTP-543 open label, long-term extension study at the 2nd JAK Inhibitors Drug Development Summit.

Concert Pharmaceuticals, Inc. (CNCE) CEO Roger Tung on Q1 2021 Results - Earnings Call Transcript

LEXINGTON, Mass.--(BUSINESS WIRE)---- $CNCE #CNCE--Concert reports financial results for the first quarter of 2021.

LEXINGTON, Mass.--(BUSINESS WIRE)---- $CNCE #CNCE--Concert will present a corporate overview at the H.C. Wainwright and Oppenheimer virtual conferences in March.

Concert Pharmaceuticals, Inc. (CNCE) CEO Roger Tung on Q4 2020 Results - Earnings Call Transcript